Health Economics

Featured

Financing the efficient delivery of medical services while reducing costs for consumers as well as health care providers is among the most challenging domestic policy problems many countries face. RAND addresses health economics issues through innovative, high-profile research in an effort to improve the efficiency of health care organizations, reduce costs for providers and consumers, and improve financing in health care markets.

  • Vials of COVID-19 vaccine, photo by MarsBars/Getty Images

    Report

    COVID-19 'Vaccine Nationalism' Could Cost $1.2 Trillion a Year

    Oct 28, 2020

    Nationalistic behavior by governments may exclude some countries from access to COVID-19 vaccines. This could cost the world economy up to $1.2 trillion a year in GDP. A globally coordinated effort to fight the pandemic is key, not only from a public health perspective but also an economic one.

  • Bottles of drugs on the shelf at the Rock Canyon Pharmacy, in Provo, Utah, May 9, 2019, photo by George Frey/Reuters

    Report

    U.S. Prescription Drug Prices Are 2.56 Times Those in Other Countries

    Jan 28, 2021

    Prices for prescription drugs in the United States in 2018 were 256 percent of those in 32 comparison countries. For brand-name drugs, U.S. prices were 344 percent higher. But for generic drugs, they were only 84 percent of the average paid in other nations.

Explore Health Economics

Research conducted by